The pharma industry in India continues to grow rapidly and as it does the regulatory environment continues to shift. With over thirty years experience in pharma Tapan Ray has a broad overview of ...

This optimism is supported by strong fundamentals, with InvestingPro data showing impressive revenue growth of 11.5% and an industry-leading ... a highly competitive pharmaceutical landscape ...

The healthcare analytics and clinical research services industry has been experiencing significant shifts, driven by factors such as pharmaceutical company reorganizations, changes in biotech ...

All eyes are on how Trump’s drug order would impact Indian pharma industry. Industry experts are closely watching the implications of the US President’s strategy on the Indian pharma sector.

Trade data underscores the pharmaceutical sector's growing role in Kuwait’s economy, reinforcing the strategic importance of international partnerships to meet domestic healthcare needs. Industry ...

What does this mean for Indian pharmaceutical companies ... Ergo, Trump is determined to bring the global pharma industry to heel for charging exorbitant prices to US consumers.

improve market access and thus boost pharmaceutical exports from India. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd, said, “The implementation of UK–India free trade ...

Going by the same logic, pharma stocks should be resilient and consistent in delivering gains year after year. However, among large Indian pharma ... pharmaceutical industry is facing a shift ...

A fresh threat by US president Donald Trump on Monday that sector-specific tariffs on pharmaceuticals could be announced in the next two weeks has hammered the stocks of Indian drug-makers on ...

Indian Pharmaceutical Alliance (IPA), which represents large pharma firms in the country that account for nearly 80 per cent of India’s pharma exports by value, felt that the generics industry ...